|
Date of decision
|
12 July 2000
|
|
|
Case number
|
G 0003/98
- EBA
|
|
|
Application number
|
83901021.2
|
|
|
|
|
|
|
Title of the application
|
Materials and methods for herpes simplex virus vaccination
|
|
|
Applicant name
|
University Patents, Inc.
|
|
|
Opponent name
|
SmithKline Beecham Biologicals SA
|
|
Headnote
For the calculation of the six-month period referred to in
Article 55(1) EPC, the relevant date is the date of the actual
filing of the European patent application; the date of priority
is not to be taken account of in calculating this period.
REMARK:
Der Text der Entscheidung G 3/98 entspricht dem deutschen Text
der Entscheidung G 2/99
Le texte de la décision G 3/98 correspond au texte allemand de
la décision G 2/99
The text of decision G 3/98 corresponds to the German text of
decision G 2/99
|
|
|
Keywords
Admissibility of referral - significance of the point of law in
the appeal proceedings (yes)
Calculation of the six-month period under Art. 55 EPC - relevant
date - date of actual filing of the application
|
|
|
Cited Decisions
|
Federal Court of Justice (DE) 5 December 1995 (Coriolis force)
Federal Court (CH) 19 August 1991 (Stacker)
Hoge Raad (NL) 23 June 1995 (Follicle stimulation hormone II)
Opposition Division (EPO) 8 July 1991 (PASSONI/Stand structure)
|
|
|
|
